Tech Company Financing Transactions
MindRank Funding Round
On 7/9/2026, MindRank raised $52 million in Series B financing from private investors.
Transaction Overview
Company Name
Announced On
7/9/2026
Transaction Type
Venture Equity
Amount
$52,000,000
Round
Series B
Investors
Proceeds Purpose
The financing will support the continued advancement of MAP, as well as the progression of MindRank's clinical and preclinical pipeline.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Shanghai, Undisclosed
China
Shanghai, Undisclosed
China
Phone
Undisclosed
Website
Email Address
Overview
MindRank is a clinical stage AI-powered drug discovery company. Our Mission: To transform drug discovery and development by continuously inventing and integrating innovations across machine learning, biology and chemistry. Our ultimate goal is to find better drugs, treat more diseases, and help more patients. In addition to speeding up and reducing costs of drug discovery, we aim to discover innovative therapies and increase the overall drug R&D successful rate.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Zhangming Niu
Browse more venture capital transactions:
Prev: 7/9/2026: Aria venture capital transaction
Next: 7/9/2026: Catalyxx venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs